KBC Group NV - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
KBC Group NV ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$104,000
-60.9%
15,600
-50.0%
0.00%
Q2 2021$266,000
+82.2%
31,200
+88.0%
0.00%
Q1 2021$146,000
-87.0%
16,6000.0%0.00%
Q4 2020$1,122,000
+725.0%
16,6000.0%0.00%
Q3 2020$136,000
-15.0%
16,6000.0%0.00%
-100.0%
Q2 2020$160,000
+247.8%
16,600
+147.8%
0.00%
Q1 2020$46,000
-54.0%
6,7000.0%0.00%
-100.0%
Q4 2019$100,000
-4.8%
6,700
-34.8%
0.00%0.0%
Q3 2019$105,00010,2700.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders